These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4805083)

  • 21. Specific binding of oestradiol by oestrogen induced prolactin secreting pulmonary tumours in rats.
    Attramadal A; Haug E; Naess O; Skullerud K
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():21-31. PubMed ID: 4451121
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats.
    Wiklund J; Wertz N; Gorski J
    Endocrinology; 1981 Nov; 109(5):1700-7. PubMed ID: 7297500
    [No Abstract]   [Full Text] [Related]  

  • 23. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments.
    Harvey PW
    J Appl Toxicol; 2005; 25(3):179-83. PubMed ID: 15856525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.
    Harvey PW
    J Appl Toxicol; 2012 Jan; 32(1):1-9. PubMed ID: 22095846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mammary tumor growth by dexamethasone in rats in the presence of high serum prolactin levels.
    Aylsworth CF; Sylvester PW; Leung FC; Meites J
    Cancer Res; 1980 Jun; 40(6):1863-6. PubMed ID: 7371016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natural history of prolactin and GH secretion in mice with high and low incidence of mammary tumors.
    Sinha YN; Selby FW; Vanderlaan WP
    Endocrinology; 1974 Mar; 94(3):757-64. PubMed ID: 4813677
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
    Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN
    Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of ovariectomy-induced rat mammary tumor regression by a mammosomatotropic tumor.
    Diamond EJ; Khan S; Koprak S; Hollander VP
    Cancer Res; 1978 Aug; 38(8):2239-45. PubMed ID: 208762
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prolactin and human cancer of the breast. I. Levels of correlation].
    Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic administration of pharmacological doses of ovine prolactin decreases hormone disappearance rate.
    Diamond EJ; Khan S; Paul MA; Koprak S; Hollander VP
    Endocrinology; 1980 Mar; 106(3):952-8. PubMed ID: 7353554
    [No Abstract]   [Full Text] [Related]  

  • 31. Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats.
    Rothschild TC; Boylan ES; Calhoon RE; Vonderhaar BK
    Cancer Res; 1987 Aug; 47(16):4508-16. PubMed ID: 3607779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of prolactin in experimental breast cancer. 2].
    Nagasawa H
    Horumon To Rinsho; 1971 Sep; 19(9):707-11. PubMed ID: 4940393
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of prolactin messenger RNA in rat anterior pituitary by in situ hybridization.
    Lloyd RV; Landefeld TD
    Am J Pathol; 1986 Oct; 125(1):35-44. PubMed ID: 3777138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin and breast cancer.
    Lancet; 1972 Nov; 2(7787):1129-30. PubMed ID: 4117209
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
    Pavić S; Pavić Z
    Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
    Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of nephrectomy on the incidence of breast carcinoma in irradiated parabiosed rats.
    Brown CE; Chute RN; Porter MW; Warren S
    Cancer Res; 1975 Jan; 35(1):37-44. PubMed ID: 1109795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin and estrogen receptors in breast cancer.
    McGuire WL; Chamness GC; Horwitz KB; Zava DT
    Pathobiol Annu; 1977; 7():191-211. PubMed ID: 201904
    [No Abstract]   [Full Text] [Related]  

  • 40. [Proceedings: Role of prolactin in breast cancer. (2)].
    Daigo K; Kato Y; Fujiwara T; Chihara K; Imura H
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):507. PubMed ID: 4476535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.